Multiplicom N.V.

📍 Niel, Belgium🗓 Founded 2011👥 23 employees💰 Last funded Oct 2015
Biotechnology🌐 multiplicom.com
Website LinkedIn
On January 20, 2017, Agilent Technologies acquired Multiplicom N.V. With the completion of the acquisition, the Multiplicom team is a part of the Genomics Division within Agilent’s Diagnostics & Genomics Group. Go to https://www.linkedin.com/showcase/agilent-genomics for all of our latest updates! Multiplicom develops, manufactures and commercializes molecular diagnostic assays, provided as kits, which enable personalized medicine. Founded in 2011 as a spin-off from the University of Antwerp and VIB, Multiplicom achieved end of 2012 its first CE-IVD-certification for the BRCA MASTR Dx assay for breast and ovarian cancer predisposition. It was the first company in Europe achieving a BRCA CE-IVD certification and it continues to develop and market quality controlled MPS-based assays. Therefore, it enables clinical laboratories to diagnose patients with a genetic disease or predisposition, steer cancer therapy, and identify congenital defects early in pregnancy. The Multiplicom N.V. site, located at Galileïlaan 18 in Niel, Belgium, operates a Quality Management System to design, develop, manufacture and distribute CE-IVD products according to ISO 13485:2012.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2011
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Belgium
1
Frequently asked questions
Who invested in Multiplicom N.V.?
Multiplicom N.V. has 1 investors on record on gritt.io, 1 mid-stage.
When did Multiplicom N.V. last raise funding?
The most recent investment in Multiplicom N.V. recorded on gritt.io was in October 2015.
When was Multiplicom N.V. founded?
Multiplicom N.V. was founded in 2011.
What industry is Multiplicom N.V. in?
Multiplicom N.V. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Multiplicom N.V. based?
Multiplicom N.V. is headquartered in Niel, Belgium.